n = 160 (100%) | |
---|---|
Age in years, mean ± SD | 56 ± 16 |
Male sex, n (%) | 108 (68) |
ASA classification | |
I | 33 (21) |
II | 65 (41) |
III | 52 (32) |
IV | 10 (6) |
Location of NSTI, n (%) | |
Head/neck | 8 (5) |
Trunk | 16 (10) |
Perineum | 44 (27) |
Upper extremity | 19 (12) |
Lower extremity | 72 (45) |
Multiple body areas involved | 1 (1) |
Estimated TBSA affected in %a, median (IQR) | 3 (2–6) |
0–5% | 111 (70) |
6–10% | 36 (23) |
11–15% | 7 (4) |
> 15% | 4 (3) |
Cultured micro-organism from incisional biopsy, n (%) | |
Monomicrobial | 102 (64) |
Group A Streptococcus | 74 (72) |
Other Streptococcus spp. | 10 (10) |
Staphylococcus aureus | 7 (7) |
Escherichia coli Pseudomonas spp. Clostridium spp. Otherb | 3 (3) 2 (2) 1 (1) 5 (5) |
Polymicrobial | 55 (34) |
Escherichia coli involved Pseudomonas spp. involved Clostridium spp. involved | 18 (32) 3 (5) 7 (12) |
Negative cultures | 3 (19) |